William C. McBride, MD

William C. McBride,

Contact Dr. McBride

901 Walnut Street
Suite 400
Philadelphia, PA 19107

(215) 955-4087
(215) 923-6792 fax

Most Recent Peer-reviewed Publications

  1. N-Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease
  2. Prevalence of Dyskinesia and off by 30-Minute Intervals through the Day and Assessment of Daily Episodes of Dyskinesia and OFF: Novel Analyses of Diary Data from Gocovri Pivotal Trials
  3. Corrigendum: Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: An expert consensus (CNS Spectrums (2018) 23:6 (402-413) DOI: 10.1017/S1092852918001359)
  4. Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: An expert consensus
  5. Effective management approaches for psychosis in patients with parkinson disease
  6. Erratum to: Managing neurogenic orthostatic hypotension in a patient presenting with pure autonomic failure who later developed Parkinson disease (Clinical Autonomic Research, (2017), 27, S1, (9-11), 10.1007/s10286-017-0428-4)
  7. Differential diagnosis of suspected neurogenic orthostatic hypotension in a patient with Parkinson disease
  8. Managing supine hypertension in a patient with non-diabetic autonomic neuropathy receiving droxidopa for neurogenic orthostatic hypotension
  9. Managing neurogenic orthostatic hypotension in a patient presenting with pure autonomic failure who later developed Parkinson disease
  10. Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease
  11. The emerging role of pimavanserin in the management of Parkinson's disease psychosis
  12. Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective
  13. N-Acetyl cysteine may support dopamine neurons in Parkinson's disease: Preliminary clinical and cell line data
  14. Who is helping whom? Manuscript support and transfer of value
  15. Disease modification
  16. Posterior reversible encephalopathy syndrome presenting as opsoclonus-myoclonus
  17. Pearls & Oy-sters: Fibrocartilaginous embolism myelopathy
  18. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location
  19. Treatment of dyskinesias in Parkinson’s disease: New use of an old drug
  20. Schistosoma mansoni in family 5 years after safari [1]